OrthoPediatrics Corp. (KIDS) Financial Statements (2024 and earlier)

Company Profile

Business Address 2850 FRONTIER DRIVE
WARSAW, IN 46582
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments93,185107,730118,290120,13351,16145,025
Cash and cash equivalents9,71334,6568,99135,42337,19817,957
Short-term investments83,47273,074109,29984,71013,96327,068
Restricted cash and investments1,5961,4811,4711,4491001,363
Receivables33,84926,83824,80026,18425,43417,911
Inventory, net of allowances, customer advances and progress billings90,98384,92278,19274,04167,48464,077
Inventory90,98384,92278,19274,04167,48464,077
Other undisclosed current assets3,6424,0053,9662,7513,9693,048
Total current assets:223,255224,976226,719224,558148,148131,424
Noncurrent Assets
Property, plant and equipment40,07136,91634,28636,31336,60131,068
Intangible assets, net (including goodwill)170,930164,398166,722169,183146,192138,503
Goodwill82,91184,12786,82188,04471,70770,987
Intangible assets, net (excluding goodwill)88,01980,27179,90181,13974,48567,516
Other noncurrent assets614     
Total noncurrent assets:211,615201,314201,008205,496182,793169,571
TOTAL ASSETS:434,870426,290427,727430,054330,941300,995
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities29,04922,93417,89423,52726,76519,011
Employee-related liabilities6,3236,0874,433
Accounts payable20,89016,69211,15010,88114,59114,578
Accrued liabilities8,1596,2426,7446,3236,087 
Debt   144   
Other liabilities5,4014,1385,0183,7692,9492,249
Other undisclosed current liabilities9,8618,1467,8151,4501,49913,073
Total current liabilities:44,31135,21830,87128,74631,21334,333
Noncurrent Liabilities
Long-term debt and lease obligation68872576379931,836872
Long-term debt, excluding current maturities68872576379931,836872
Liabilities, other than long-term debt6,1328,9779,4269,35733,05036,056
Deferred income tax liabilities5,5646,0225,9545,4576,2804,335
Other liabilities562645492440300241
Business combination, contingent consideration, liability 62,3102,9803,46026,47031,480
Other undisclosed noncurrent liabilities3,4278,2158,0197,8227,62614,690
Total noncurrent liabilities:10,24717,91718,20817,97872,51251,618
Total liabilities:54,55853,13549,07946,724103,72585,951
Equity
Equity, attributable to parent380,312373,155378,648383,330227,216215,044
Common stock666655
Additional paid in capital574,677562,769560,810559,339418,354396,425
Accumulated other comprehensive income (loss)(7,911)(6,046)(5,400)(7,095)(3,684)5,740
Accumulated deficit(186,460)(183,574)(176,768)(168,920)(187,459)(187,126)
Total equity:380,312373,155378,648383,330227,216215,044
TOTAL LIABILITIES AND EQUITY:434,870426,290427,727430,054330,941300,995

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues39,55931,58830,99434,95032,92823,417
Cost of revenue
(Cost of Goods and Services Sold)
(9,534)(8,027)(9,770)(9,061)(7,947)(4,851)
Gross profit:30,02523,56121,22425,88924,98118,566
Operating expenses(35,611)(32,152)(29,533)(32,850)(28,724)(24,952)
Operating loss:(5,586)(8,591)(8,309)(6,961)(3,743)(6,386)
Nonoperating income (expense)2,2991,21141321,3572,971(3,031)
Other nonoperating income (expense)289331(128)(945)(827)105
Income (loss) from continuing operations before income taxes:(3,287)(7,380)(7,896)14,396(772)(9,417)
Income tax expense (benefit)401574484,143439317
Income (loss) from continuing operations:(2,886)(6,806)(7,848)18,539(333)(9,100)
Income (loss) before gain (loss) on sale of properties:18,539(333)(9,100)
Net income (loss) attributable to parent:(2,886)(6,806)(7,848)18,539(333)(9,100)
Other undisclosed net income (loss) available to common stockholders, basic   151(353)  
Net income (loss) available to common stockholders, diluted:(2,886)(6,806)(7,697)18,186(333)(9,100)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):(2,886)(6,806)(7,848)18,539(333)(9,100)
Comprehensive income (loss):(2,886)(6,806)(7,848)18,539(333)(9,100)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,865)(646)1,695(3,411)(9,424)(2,751)
Comprehensive income (loss), net of tax, attributable to parent:(4,751)(7,452)(6,153)15,128(9,757)(11,851)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: